MDPI and ACS Style
Yamaguchi, K.; Ninomiya, S.; Matsumoto, T.; Nakamura, N.; Nakamura, H.; Kitagawa, J.; Kanemura, N.; Hara, T.; Fujigaki, S.; Yamamoto, Y.;
et al. Indoleamine 2,3-Dioxygenase Activity Is Increased in Myelodysplastic Syndrome Patients. Hemato 2020, 1, 77-85.
https://doi.org/10.3390/hemato1020011
AMA Style
Yamaguchi K, Ninomiya S, Matsumoto T, Nakamura N, Nakamura H, Kitagawa J, Kanemura N, Hara T, Fujigaki S, Yamamoto Y,
et al. Indoleamine 2,3-Dioxygenase Activity Is Increased in Myelodysplastic Syndrome Patients. Hemato. 2020; 1(2):77-85.
https://doi.org/10.3390/hemato1020011
Chicago/Turabian Style
Yamaguchi, Kimihiro, Soranobu Ninomiya, Takuro Matsumoto, Nobuhiko Nakamura, Hiroshi Nakamura, Junichi Kitagawa, Nobuhiro Kanemura, Takeshi Hara, Suwako Fujigaki, Yasuko Yamamoto,
and et al. 2020. "Indoleamine 2,3-Dioxygenase Activity Is Increased in Myelodysplastic Syndrome Patients" Hemato 1, no. 2: 77-85.
https://doi.org/10.3390/hemato1020011